Skip to content
OpenCapital
Get started

Globus Medical GMED Musculoskeletal Solutions And Enabling Technologies — Revenue

Discontinued — last reported Q3 '25

Similar metrics at other companies

Baxter International logo
BAXSurgical Solutions — Net Sales
$77M+11.6%
Zimmer Biomet Holdings logo
ZBHTechnology And Data Bone Cement And Surgical — Revenue
$171.8M+14.6%
Boston Scientific logo
BSXMedSurg — Net sales of reportable segments
$1.7B+5.7%
Zimmer Biomet Holdings logo
ZBHSET — Revenue
$562.2M+19.5%
Fortive logo
FTVMedical technologies — Sales
$308.1M+12.4%
Solventum logo
SOLVMedSurg — Total Net Sales
$1.23B+6.7%

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Globus Medical’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's musculoskeletal solutions and enabling technologies — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's musculoskeletal solutions and enabling technologies — revenue?
Globus Medical (GMED) reported musculoskeletal solutions and enabling technologies — revenue of $769.05M in Q3 2025.
What does musculoskeletal solutions and enabling technologies — revenue mean?
Total sales revenue from the company's primary orthopedic and surgical technology product lines.
How do you interpret musculoskeletal solutions and enabling technologies — revenue?
An increase indicates strong market demand and successful product adoption, while a decrease may signal competitive pressure or market saturation.
How does musculoskeletal solutions and enabling technologies — revenue compare across companies?
Comparable to segment-level revenue reporting for other medical device manufacturers specializing in orthopedics.